NBDF is delighted to dedicate this edition of HANDI Highlights* to the upcoming Rare Disease Day® (RDD), which is observed every year on February 28th (or 29th in leap years) all around the world. According to rarediseaseday.…
MEDICAL ADVISORY Released: February 24, 2025, 7:56 PM ESTMedical Advisory: ALTUVIIIO LOT #EY0330 OVERVIEW Sanofi is conducting a voluntary recall of ALTUVIIIO [antihemophilic factor (recombinant), Fc-…
Pfizer, Inc. has announced that they are ceasing global development and commercialization of Beqvez™, the company’s hemophilia B gene therapy product.Beqvez was designed with bioengineered adeno-associated virus (AAVs) vectors to introduce…